Clinical Trials Directory

Trials / Completed

CompletedNCT05238779

An Integrative Model for Palliative Care in End-Stage Liver Disease

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to understand the impact of palliative care in ESLD on quality of life, emergency room or hospital visits, and on care provider burden, and to work to develop the best way to provide palliative care in ESLD.

Detailed description

Patients with end-stage liver disease (ESLD) have multiple symptoms that impact their quality of life and result in more emergency room and hospital visits. Palliative care is a medical model that can help alleviate pain and suffering and reduce need for urgent medical care and can do so while continuing other appropriate medical care. While palliative care consults are used in those with ESLD, despite the pain and suffering that accompanies ESLD, palliative care is often used too little and too late.

Conditions

Interventions

TypeNameDescription
OTHERStandard of care including palliative careUsual care includes laboratory evaluations, imaging, and certain procedures and medications. In some cases of patients undergoing transplant evaluation, usual care will also include multiple visits with members of the liver transplant team. A palliative care consult will also be part of standard of care. The primary goal of the palliative care consult is not to arrange hospice (though that can be done in appropriate situations) but to identify and try to address the impacts of the disease and its symptoms on patient's life.

Timeline

Start date
2022-01-06
Primary completion
2022-12-12
Completion
2022-12-12
First posted
2022-02-14
Last updated
2023-07-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05238779. Inclusion in this directory is not an endorsement.